58:59
In Vitro Assessment of Cardiac Risk in Drug Discovery
00:07
Studying ion channels on the lysosomal membrane
00:17
Effect of hERG blocker ondansetron on action potential waveform in human stem cell cardiomyocytes
03:55
Demonstration of Endo-Lysosomal Patch Clamp Technique
01:18
Metrion's Neuroscience Services
01:19
High Throughput Screening at Metrion Biosciences
01:19
Cardiac Safety Services
54:13
Metrion Webinar – Dr. Manoj Patel
03:17
Metrion Biosciences laboratory Tour
48:06
Metrion Webinar - Dr Kris Kahlig
43:38
Metrion Webinar - Dr Greg Carr - LIBD
01:00:26
Metrion Webinar - Presented by Professor David Sheppard
50:53
Professor Stephen Tucker presents Metrion's second webinar
02:25
Metrion Newsletter Summary June 2021
04:40
Metrion Biosciences CEO Overview Presentation
01:03:08
Validation and optimization of automated patch clamp voltage-gated Ca2+ channel assays
04:14
Targeting ion channels in drug discovery
X
About
Metrion Biosciences is a specialist preclinical drug discovery CRO - your trusted partner for ion channel and cardiac safety screening. We provide highly skilled electrophysiology screening services for the support of client medicinal chemistry optimisation programmes, CiPA compliant cardiac safety profiling assays, neuroscience assays and translational assays.
Working closely with our collaborators, we also offer an expert integrated drug discovery service. Business models are flexible according to the scope of each programme, with both fee-for-service and collaborative options available.
Tags